Saturday 17 October 2026
Export YTENQ’s income statement to Excel — free account
Metabolix, Inc.
YTENQ Basic Materials Agricultural Inputs
Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow YTENQ
| Jun '24 | Mar '24 | Dec '23 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — |
+8 more quarters Free account |
P/S ratio |
0.80 | 8.55 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(1.25) | (5.28) | — | — | |
P/B ratio |
0.00 | 0.00 | — | — | |
Price to Tangible BV |
0.00 | 0.00 | — | — | |
EV/Sales |
1.07 | 7.43 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(0.16) | (0.50) | — | — | |
EV/FCF |
(0.16) | (0.50) | — | — | |
Quick Ratio |
0.10 | 0.26 | 0.22 | 0.71 | |
Current Ratio |
0.16 | 0.34 | 0.29 | 0.85 | |
Net Debt/EBITDA |
0.23 | 0.67 | 0.34 | 0.78 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.20 | 0.12 | 0.00 | 0.00 | |
Operating CF/Net income |
0.18 | 0.37 | 0.52 | 0.70 | |
Capex/Depreciation |
0.00 | 0.00 | (0.27) | 0.01 | |
Research and Development Expense of Revenue |
366.44% | 455.33% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
445.33% | 458.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
76.22% | 134.33% | 0.00% | 0.00% | |
Graham Net Nets |
(11.13) | (1.14) | — | — | |
Graham Number |
75.56 | 72.33 | — | — | |
Earnings Yield |
(2,331.87%) | (396.35%) | — | — | |
Free Cash Flow Yield |
(812.89%) | (175.07%) | — | — | |
Revenue per Share |
0.70 | 0.58 | 0.00 | 0.00 | |
Operating CF per Share |
(0.89) | (1.74) | (5.16) | (6.97) | |
Capex per Share |
0.00 | 0.00 | (0.06) | 0.00 | |
Free Cash Flow per Share |
(0.89) | (1.74) | (5.22) | (6.96) | |
Cash per Share |
1.14 | 3.08 | 3.22 | 7.52 | |
Shareholders Equity per Share |
(9.72) | (6.38) | (7.49) | 1.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(9.72) | (6.38) | (7.49) | 1.05 | |
Free Cash Flow |
(0.57) | (0.90) | (1.73) | (2.61) | |
Working Capital |
(6.46) | (4.09) | (3.46) | (0.59) | |
Capital Expenditures |
— | — | (0.02) | 0.00 | |
Net Current Asset Value |
(8.00) | (5.43) | (4.99) | (2.29) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
1.42 | 1.07 | 0.66 | 0.24 | |
Average Assets |
4.42 | 4.79 | 6.00 | 8.66 | |
Average Common Equity |
(2.83) | (1.08) | 0.96 | 3.81 |
Columns are period end dates